The Chemours
CC
13.98
-0.10
-0.71%
The Chemours
US · CC
#2748 by market cap
Listed 1970
13.98
-0.10
-0.71%
Live - 5344 symbols - heartbeat 107s ago
· 2026-10-08 07:52
Pre-market
13.98
0.00%
After-hours
13.98
0.00%
Overnight
13.98
0.00%
- Market cap
- 2.10B
- P/E (TTM)i
- -6.92
- P/Bi
- -42.88
- EPSi
- -2.57
- Div yieldi
- 2.50%
- 52W posi
- 20%
Reader sentiment
Are you bullish or bearish on CC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.40, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +0.45% YoY
Margins
- Gross margin
- 15.53%
- Operating margin
- -0.48%
- Net margin
- -6.65%
Key ratios & quality
- Enterprise valuei
- 5.64B
- Altman Z-Scorei
- 1.40
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.64B | 5.53B | 4.97B | 6.35B | 6.83B | 6.08B | 5.78B | 5.81B |
| Gross profit | 1.97B | 1.06B | 1.07B | 1.38B | 1.62B | 1.30B | 1.14B | 902.00M |
| Selling & admin expenses | 657.00M | 548.00M | 527.00M | 592.00M | 710.00M | 1.29B | 598.00M | 799.00M |
| Research & development | 82.00M | 80.00M | 93.00M | 107.00M | 118.00M | 108.00M | 109.00M | 108.00M |
| Operating profit | 1.23B | 412.00M | 406.00M | 674.00M | 786.00M | -123.00M | 421.00M | -28.00M |
| Pretax profit | 1.16B | -124.00M | 179.00M | 676.00M | 741.00M | -318.00M | 106.00M | -277.00M |
| Tax | 159.00M | -72.00M | -40.00M | 68.00M | 163.00M | -66.00M | 37.00M | 109.00M |
| Net profit | 996.00M | -52.00M | 219.00M | 608.00M | 578.00M | -252.00M | 69.00M | -386.00M |
| Basic EPS | 6 | 0 | 1 | 4 | 4 | -2 | 0 | -3 |
| Diluted EPS | 5.45 | -0.32 | 1.32 | 3.60 | 3.65 | -1.70 | 0.46 | -2.57 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.37B | 1.62B | 1.50B | 1.33B | 1.38B | 1.59B |
| Gross profit | 236.00M | 278.00M | 233.00M | 156.00M | 212.00M | 286.00M |
| Selling & admin expenses | 123.00M | 424.00M | 109.00M | 130.00M | 147.00M | 469.00M |
| Research & development | 27.00M | 28.00M | 26.00M | 27.00M | 26.00M | 27.00M |
| Operating profit | 78.00M | -174.00M | 93.00M | -5.00M | 39.00M | -210.00M |
| Pretax profit | 0 | -248.00M | 51.00M | -67.00M | -22.00M | -1.00M |
| Tax | 5.00M | 131.00M | -9.00M | -5.00M | 7.00M | 273.00M |
| Net profit | -5.00M | -379.00M | 60.00M | -62.00M | -29.00M | -274.00M |
| Basic EPS | 0 | -3 | 0 | 0 | 0 | -2 |
| Diluted EPS | -0.03 | -2.53 | 0.40 | -0.41 | -0.19 | -1.81 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.29B | 2.78B | 2.63B | 3.35B | 3.21B | 3.84B | 3.02B | 3.00B |
| Cash & ST investments | 1.20B | 943.00M | 1.11B | 1.45B | 1.10B | 1.20B | 713.00M | 670.00M |
| Inventory | 1.15B | 1.08B | 939.00M | 1.10B | 1.40B | 1.35B | 1.46B | 1.57B |
| Total assets | 7.36B | 7.26B | 7.08B | 7.55B | 7.64B | 8.25B | 7.51B | 7.38B |
| Total current liabilities | 1.71B | 1.54B | 1.44B | 1.86B | 1.89B | 2.49B | 1.82B | 1.69B |
| Short-term debt | 13.00M | 200.00M | 78.00M | 84.00M | 92.00M | 106.00M | 110.00M | 104.00M |
| Long-term debt | 3.96B | 4.03B | 4.01B | 3.72B | 3.59B | 3.99B | 4.06B | 4.10B |
| Total liabilities | 6,342,000,000.00 | 6,563,000,000.00 | 6,267,000,000.00 | 6,468,000,000.00 | 6,533,000,000.00 | 7,512,000,000.00 | 6,937,000,000.00 | 7,131,000,000.00 |
| Total equity | 1.02B | 695.00M | 815.00M | 1.08B | 1.11B | 739.00M | 572.00M | 251.00M |
| Retained earnings | 1.47B | 1.25B | 1.30B | 1.75B | 2.17B | 1.78B | 1.69B | 1.22B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.93B | 3.10B | 3.21B | 3.00B | 2.93B | 3.09B |
| Cash & ST investments | 464.00M | 502.00M | 613.00M | 670.00M | 563.00M | 671.00M |
| Inventory | 1.55B | 1.56B | 1.55B | 1.57B | 1.54B | 1.45B |
| Total assets | 7.39B | 7.49B | 7.57B | 7.38B | 7.27B | 7.15B |
| Total current liabilities | 1.67B | 1.85B | 1.88B | 1.69B | 1.61B | 1.86B |
| Short-term debt | 104.00M | 99.00M | 114.00M | 104.00M | 99.00M | 91.00M |
| Long-term debt | 4.06B | 4.10B | 4.10B | 4.10B | 4.10B | 3.84B |
| Total liabilities | 6,814,000,000.00 | 7,249,000,000.00 | 7,270,000,000.00 | 7,131,000,000.00 | 7,051,000,000.00 | 7,198,000,000.00 |
| Total equity | 580.00M | 239.00M | 300.00M | 251.00M | 216.00M | -48.00M |
| Retained earnings | 1.66B | 1.27B | 1.31B | 1.22B | 1.18B | 891.00M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.14B | 650.00M | 807.00M | 814.00M | 755.00M | 556.00M | -633.00M | 264.00M |
| Depreciation & amortization | 284.00M | 311.00M | 320.00M | 317.00M | 291.00M | 309.00M | 292.00M | 340.00M |
| Free cash flow | 642.00M | 169.00M | 540.00M | 537.00M | 448.00M | 186.00M | -993.00M | 51.00M |
| Dividends paid | -148.00M | -164.00M | -164.00M | -164.00M | -154.00M | -149.00M | -148.00M | -78.00M |
| Stock buybacks / issuance | -644.00M | -322.00M | 0 | -173.00M | -495.00M | -69.00M | 0 | 0 |
| Ending cash balance | 1.20B | 943.00M | 1.11B | 1.55B | 1.30B | 1.81B | 763.00M | 724.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -112.00M | 93.00M | 146.00M | 137.00M | -44.00M | 158.00M |
| Depreciation & amortization | 88.00M | 92.00M | 79.00M | 81.00M | 79.00M | 80.00M |
| Free cash flow | -196.00M | 50.00M | 105.00M | 92.00M | -93.00M | 114.00M |
| Dividends paid | -37.00M | -13.00M | -13.00M | -15.00M | -13.00M | -13.00M |
| Stock buybacks / issuance | 27.00M | 20.00M | -- | -- | 16.00M | 16.00M |
| Ending cash balance | 514.00M | 553.00M | 665.00M | 724.00M | 615.00M | 723.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 106.19 | -6.11 | 29.16 | 64.20 | 52.83 | -25.81 | 12.83 | -90.40 |
| ROA %i | 13.58 | -0.71 | 3.05 | 8.31 | 7.61 | -3.00 | 1.09 | -5.18 |
| ROIC %i | 23.36 | 1.97 | 7.26 | 15.25 | 14.05 | -1.66 | 5.30 | -3.61 |
| 5-year avg ROE %i | 54.94 | 51.39 | 58.17 | 69.77 | 49.26 | 22.53 | 25.86 | 1.22 |
| EBIT margin %i | 20.34 | 1.52 | 7.83 | 13.57 | 13.31 | -1.83 | 6.76 | -0.14 |
| FCF / sales %i | 9.67 | 3.06 | 10.87 | 8.56 | 6.58 | 3.09 | -- | 0.88 |
| Current ratioi | 1.93 | 1.80 | 1.83 | 1.80 | 1.70 | 1.54 | 1.66 | 1.78 |
| Quick ratioi | 1.21 | 1.05 | 1.12 | 1.17 | 0.91 | 0.73 | 0.81 | 0.80 |
| Debt / assetsi | 53.95 | 61.60 | 60.39 | 52.81 | 50.79 | 52.10 | 58.16 | 59.52 |
| LT debt / equityi | 390.43 | 619.88 | 516.48 | 361.05 | 342.19 | 568.93 | 745.53 | 1,716.00 |
| Interest coveragei | 6.92 | 0.40 | 1.85 | 4.65 | 5.55 | -0.53 | 1.48 | -0.03 |
| Revenue CAGR (3Y) %i | 5.10 | 0.77 | -7.03 | -1.49 | 7.32 | 6.95 | -3.05 | -5.26 |
| Net income CAGR (3Y) %i | -- | -- | -33.54 | -15.14 | -- | -- | -51.58 | -- |
| FCF CAGR (3Y) %i | -- | -12.93 | 33.10 | -5.78 | 38.40 | -29.90 | -- | -51.53 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 4.21 | -85.83 | -67.02 | -90.40 | -103.27 | -323.40 |
| ROA %i | 0.36 | -5.59 | -4.26 | -5.18 | -5.59 | -4.15 |
| ROIC %i | 4.79 | -4.15 | -2.23 | -3.61 | -5.16 | -3.22 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 5.60 | -0.07 | 1.37 | -0.14 | -0.46 | 3.85 |
| FCF / sales %i | -- | -- | -- | 0.88 | 2.65 | 3.76 |
| Current ratioi | 1.75 | 1.68 | 1.71 | 1.78 | 1.82 | 1.66 |
| Quick ratioi | 0.79 | 0.79 | 0.83 | 0.80 | 0.82 | 0.85 |
| Debt / assetsi | 59.25 | 58.85 | 58.32 | 59.52 | 60.42 | 57.62 |
| LT debt / equityi | 738.69 | 1,817.72 | 1,443.29 | 1,716.00 | 1,996.28 | -- |
| Interest coveragei | 1.21 | -0.01 | 0.30 | -0.03 | -0.10 | 0.82 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Titanium Technologies is the largest reported line at 41.55% of revenue, across 4 reported segments.
- No single line clears half of revenue; Thermal & Specialized Solutions is next at 37.15%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Titanium Technologies41.55%
Thermal & Specialized Solutions37.15%
Advanced Performance Materials20.49%
Other Non-Reportable Segment0.82%
Quote time 2026-10-08 07:52:29 · For reference only, not investment advice and not tailored to your situation.